| 来源类型 | Article
|
| 规范类型 | 其他
|
| DOI | 10.5367/000000000101298603
|
| ISBN | 1476-1297
|
| Spin-in or spin-out? Corporate ventures in life sciences. |
| Tidd, Joe; Barnes, Simon
|
| 发表日期 | 2000
|
| 出处 | International Journal of Entrepreneurship and Innovation Management
|
| 出版者 | Inderscience
|
| 出版年 | 2000
|
| 页码 | 109-116
|
| 语种 | 英语
|
| 摘要 | This paper examines the variety of corporate venturing activities in the pharmaceutical and life science sectors, identifies the range of initiators, motives and structures, and evaluates the potential opportunities for professional venture capital firms. On the one hand, pharmaceutical companies need to maintain the new product pipeline that has increased the demand for technology acquisition, and on the other, mergers and rationalization within the sector have resulted in a significant growth in technology divestment. Both trends have boosted corporate venturing activity. The study examines the venture activities of nine pharmaceutical firms, fourteen life science companies and seven corporate venture capital funds. The authors conclude that, while there is a wide range of venturing options, there is considerable confusion in the industry over ends and means. Specifically, many firms have failed to differentiate sufficiently between strategic, financial and operational goals, and have therefore created inappropriate forms of corporate venture. |
| URL | http://sro.sussex.ac.uk/id/eprint/20671/
|
| 来源智库 | Science Policy Research Unit (United Kingdom)
|
| 引用统计 |
|
| 资源类型 | 智库出版物
|
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/466949
|
推荐引用方式
GB/T 7714 |
Tidd, Joe,Barnes, Simon. Spin-in or spin-out? Corporate ventures in life sciences.. 2000.
|
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
